Breast cancers can be subdivided into three clinically distinct subtypes based on the expression of specific receptors (estrogen receptor (ER)/progesterone receptor (PR) positive, Her2/Neu or triple negative), all of which have the capacity to metastasize to the bone [4]. This evidence concerns the gene ERBB2 and breast carcinoma.